Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00664820 (ClinicalTrials.gov) | March 2008 | 18/4/2008 | Effects of Probiotics on Rheumatoid Arthritis Patients | Effects of Probiotics on Rheumatoid Arthritis Patients | Rheumatoid Arthritis | Dietary Supplement: Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 | Lawson Health Research Institute | University of Western Ontario, Canada;St. Joseph's Health Care London | Completed | 18 Years | 80 Years | All | 50 | N/A | Canada |